Literature DB >> 11095342

Modification of cardiac function in cirrhotic patients with and without ascites.

V Valeriano1, S Funaro, R Lionetti, O Riggio, G Pulcinelli, P Fiore, A Masini, S De Castro, M Merli.   

Abstract

OBJECTIVES: Abnormalities in cardiac function have been reported in liver cirrhosis, suggesting a latent cardiomyopathy in these patients. In this study we investigated cardiac function in cirrhotic patients and in controls.
METHODS: A total of 20 cirrhotic patients without previous or ongoing ascites, 20 cirrhotic patients with moderate-to-severe ascites, and 10 healthy controls were studied by two-dimensional Doppler echocardiography. Cardiac dimensions and left and right ventricular function were evaluated. The left ventricular geometric pattern was calculated according to Ganau's criteria. Diastolic function was evaluated by the peak filling velocity of E wave and A wave, E/A ratio, and deceleration time of E wave. The pulmonary systolic arterial pressure was also estimated in patients with tricuspid insufficiency.
RESULTS: Right and left atrium and right ventricle diameters were significantly enlarged in cirrhotic patients versus controls. E/A ratio was decreased (p < 0.05) in patients with ascites (0.9 +/- 0.2) versus those without ascites (1.3 +/- 0.4) and controls (1.3 +/- 1). The estimated pulmonary systolic arterial pressure was slightly elevated in patients with ascites (35 +/- 5 mm Hg, six patients) versus those with no ascites (28 +/- 5, 10 patients) and controls (27 +/- 8, 6 controls, analysis of variance, p < 0.05). The pattern of left ventricular geometry was normal in the majority of patients. Nitrite and nitrate levels were increased in cirrhotics irrespective of the presence of ascites.
CONCLUSIONS: Liver cirrhosis is associated with enlarged right cardiac chambers. Diastolic dysfunction and mild pulmonary hypertension are evident in cirrhotic patients with ascites. These changes do not depend on variations in the left ventricular geometry.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095342     DOI: 10.1111/j.1572-0241.2000.03252.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  32 in total

Review 1.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

Review 2.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

Review 3.  Cardiac evaluation of liver transplant candidates.

Authors:  Mercedes Susan Mandell; Joann Lindenfeld; Mei-Yung Tsou; Michael Zimmerman
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

4.  Diastolic dysfunction characterizes cirrhotic cardiomyopathy.

Authors:  Piyush O Somani; Qais Contractor; Ajay S Chaurasia; Pravin M Rathi
Journal:  Indian Heart J       Date:  2014-07-23

Review 5.  Left ventricular function assessment in cirrhosis: Current methods and future directions.

Authors:  Francisco Sampaio; Joana Pimenta
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

6.  Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation.

Authors:  Khemika Khemakanok; Anant Khositseth; Suporn Treepongkaruna; Sumate Teeraratkul; Wichai Pansrimangkorn; Surasak Leelaudomlipi; Uthen Bunmee; Suthus Sriphojanart
Journal:  Hepatol Int       Date:  2015-10-13       Impact factor: 6.047

Review 7.  Cirrhotic cardiomyopathy: a cardiologist's perspective.

Authors:  Natig Gassanov; Evren Caglayan; Nasser Semmo; Gero Massenkeil; Fikret Er
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

8.  Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt.

Authors:  Massimo Cazzaniga; Francesco Salerno; Giovanni Pagnozzi; Elena Dionigi; Stefania Visentin; Ilaria Cirello; Daniele Meregaglia; Antonio Nicolini
Journal:  Gut       Date:  2006-11-29       Impact factor: 23.059

9.  Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

Authors:  J H Henriksen; J P Gøtze; S Fuglsang; E Christensen; F Bendtsen; S Møller
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 10.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.